---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-030263"
form_type: "8-K"
ticker: "CLNN"
cik: "0001822791"
company_name: "Clene Inc."
filed_at: "2024-09-30T23:59:59+00:00"
generated_at: "2026-05-31T00:50:37.976976+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Clene announces $7.3M registered direct offering and concurrent private placements

## Summary
- Gross proceeds ~$7.3M; shares/pre-funded warrants at $4.713 combined with warrants ($4.82 strike, 5-year term).
- Warrants exercisable immediately; lock-up until later of 45 days or FDA meeting outcome announcement.
- Directors/officers bought 122,819 shares at $4.875/warrant package; existing investors also participated.
- Proceeds to fund clinical development of lead candidate CNM-Au8 (ALS/MS) and general corporate purposes.
- Canaccord Genuity acted as sole placement agent; closing expected on or about October 1, 2024.

## SEC filing metadata
- accession: 0001437749-24-030263
- form_type: 8-K
- ticker: CLNN
- cik: 0001822791
- company_name: Clene Inc.
- filed_at: 2024-09-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822791/000143774924030263/0001437749-24-030263-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822791/000143774924030263/clnn20240928_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-030263
- JSON: https://secwatch.observer/filing/0001437749-24-030263.json
- Plain text: https://secwatch.observer/filing/0001437749-24-030263.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.